Inventor · disambiguated record
Janine Nicolai
Also filed as: NICOLAI JANINE
3 granted patents·6 pending applications·1 citations·filing 2017–2024
50Inventor score
Top patents by PatentIndex Score
9 records- 0176US2025154175A1Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2024·Application pending·0 cites
- 0275US11098063B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2018·Granted Aug 24, 2021·1 cites·13 claims
- 0367US12180227B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 0459US2022259228A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2021·Application pending·0 cites
- 0550US2021024545A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2017·Application pending·0 cites
- 0642US2020093737A1Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapyBayer Pharma AG·Filed 2017·Application pending·0 cites
- 0738US2021393624A1Process for producing pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapyBAYER AG·Filed 2019·Application pending·0 cites
- 0837US2020085734A1Pharmaceutical dosage forms containing task-i and task-3 channel inhibitors, and the use of same in breathing disorder therapyBayer Pharma AG·Filed 2017·Application pending·0 cites
- 0936US11208422B2Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitorsBayer Pharma AG·Filed 2018·Granted Dec 28, 2021·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →